Afuco™ Anti-Human GPCR ADCC Therapeutic Antibody, ADCC Enhanced

Anti-GPCR ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies targeting GPCR are implicated in a wide variety of diseases such as rheumatoid arthritis and Crohn disease, as well as metabolic disease and cancer.
Supplier Creative Biolabs
Product # AFC-315CL
Pricing Inquiry
Host Human
Target GPCR
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback